COV - Covidien Ltd. Profile, Stock Quotes, Financial Analysis, Charts, Fundamentals

COVIDIEN LTD. (COV)

Other Ticker:

Sector • Healthcare Industry • Medical Equipment & Supplies

Price: $0.0000 $0.00

Day's High:	0.00	Week Perf:
Day's Low:	$ 0.00	30 Day Perf:
Volume (M):	0	52 Wk High:	$ 0.00
Volume (M$):	$ 0	52 Wk Avg:	$0.00
Open:	$0.00	52 Wk Low:	$0.00

COV Charts & Quotes

COV Charts & Quotes

Description of Company's Segments

Market Capitalization (Millions $)	-
Shares Outstanding (Millions)	458
Employees	39,500
Revenues (TTM) (Millions $)	10,706
Net Income (TTM) (Millions $)	1,775
Cash Flow (TTM) (Millions $)	237
Capital Exp. (TTM) (Millions $)	352

Covidien Ltd.
We are a global leader in the development, manufacture and sale of healthcare products for use in clinical and home settings. Our products are found in almost every hospital in the United States, and we have a significant and growing presence in non-U.S. markets. Our mission is to create and deliver innovative healthcare solutions, developed in collaboration with medical professionals, which enhance the quality of life for patients and improve outcomes for our customers and our shareholders.

COV is expected to report next financial results on July 20, 2020.

Next quarterly dividend payout on August 25, 2020.

Covidien Ltd.'s Segments


Medical Devices	Segment	84.81 %	of total Revenue
Advanced Surgical	Segment	34.55 %	of total Revenue
General Surgical	Segment	14.33 %	of total Revenue
Total Surgical Solutions	Segment	48.88 %	of total Revenue
Airway & Ventilation Products	Segment	6.18 %	of total Revenue
Patient Monitoring	Segment	9.34 %	of total Revenue
Nursing Care	Segment	9.57 %	of total Revenue
Patient Care	Segment	10.09 %	of total Revenue
Total Respiratory Patient Care	Segment	35.18 %	of total Revenue
Peripheral Vascular	Segment	11.47 %	of total Revenue
Neurovascular	Segment	4.47 %	of total Revenue
Total Vascular Therapies	Segment	15.93 %	of total Revenue
Medical Supplies	Segment	15.19 %	of total Revenue

• View Complete Report

	Company Estimates
	• Revenue Outlook Covidien Ltd. does not provide revenue guidance. • Earnings Outlook COVIDIEN LTD. does not provide earnings estimates.

Geographic Revenue Dispersion
United States	49.57 %
Non U.S. Developed Markets	35.03 %
Emerging Markets	15.4 %

News

Clean Energy Technologies Inc

Clean Energy Technologies Inc announced fourth quarter operating loss of $-0.083499 millions

In the fourth quarter Clean Energy Technologies Inc reached break-even of $-0.00 per share compared to $-0.00 a year ago and from $0.00 per share from the previous quarter.

Sales increased sharply by 1219.3% to $1.15 millions from $0.09 millions in the same quarter a year ago and sequentially Sales doubled by 812.66 % from $0.13 millions.

North American Nickel Inc

North American Nickel Inc announced fourth quarter operating loss of $-1.816186 millions

In the fourth quarter North American Nickel Inc increased losses of $-0.28 per share compared to $0.00 a year ago and from $0.00 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Marimed Inc

Marimed Inc announced first quarter operating income of $0.9944 millions

Marimed Inc announced earnings per share of $-0.01 and Sales of $31.77 millions in the first quarter, Company's decreased loss per share, versus $-1.27 eps, earned in the same quarter a year ago, although Marimed Inc saw it's Sales rise by 498.19% in the same period.

Pavmed Inc

Losses Widen but Revenues Unchanged

In the first quarter Pavmed Inc increased losses of $-0.33 per share compared to $-0.13 a year ago and increased losses from $-0.18 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.00 millions in the same quarter a year ago and sequentially from $0.00 millions.

Balance Labs Inc

Balance Labs Inc announced fourth quarter operating loss of $-0.105078 millions

In the fourth quarter Balance Labs Inc lost money of $-0.01 per share compared to $-0.01 a year ago and from $-0.01 per share from the previous quarter.

Sales remained unchanged to $0.00 millions from $0.01 millions in the same quarter a year ago and sequentially from $0.00 millions.

COV's Valuation	Current
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

COV's Financial Strength	Current
Quick Ratio	0.62
Working Capital Ratio	1.92
Leverage Ratio (MRQ)	0.99
Total Debt to Equity	0.49
Interest Coverage (TTM)	14.6
Debt Coverage (TTM)	0.53

Per Share	Current
Earnings (TTM)	3.9 $
Revenues (TTM)	23.38 $
Cash Flow (TTM)	0.52 $
Cash	3.97 $
Book Value	22.65 $
Dividend (TTM)	1.32 $

COV's Efficiency	Current
Revenue per Employee (TTM)	271,038
Net Income per Employee (TTM)	44,937
Receivable Turnover Ratio (TTM)	7.03
Inventory Turnover Ratio (TTM)	3.03
Asset Turnover Ratio (TTM)	0.52

COV's Profitability Ratio	Current
Gross Margin	61.21 %
Operating Margin	24.13 %
Net Margin	19.02 %
Net Cash Flow Margin	9.34 %
Effective Tax Rate (TTM)	6.23 %

Management Effectiveness	Current
Return On Assets (TTM)	8.65 %
Return On Investment (TTM)	10.1 %
Return On Equity (TTM)	17.77 %
Dividend Yield	-
Payout Ratio (TTM)	33.85 %

COV's Valuation
Price to Earnings PE Ratio (TTM)	-
Price to Earnings PE Ratio (Expected)	-
Price to Sales (TTM)	-
Price to Sales (Expected)	-
Price to Book	-
PEG (TTM)	-

COV's Financial Strength
Quick Ratio	0.62
Working Capital Ratio	1.92
Leverage Ratio (MRQ)	0.99
Total Debt to Equity	0.49
Interest Coverage (TTM)	14.6
Debt Coverage (TTM)	0.53

Per Share
Earnings (TTM)	3.9 $
Revenues (TTM)	23.38 $
Cash Flow (TTM)	0.52 $
Cash	3.97 $
Book Value	22.65 $
Dividend (TTM)	1.32 $

• View Valuation Comparisons

• View Growth Rates Comparisons

COV's Efficiency
Revenue per Employee (TTM)	271,038
Net Income per Employee (TTM)	44,937
Receivable Turnover Ratio (TTM)	7.03
Inventory Turnover Ratio (TTM)	3.03
Asset Turnover Ratio (TTM)	0.52

COV's Profitability Ratio
Gross Margin	61.21 %
Operating Margin	24.13 %
Net Margin	19.02 %
Net Cash Flow Margin	9.34 %
Effective Tax Rate (TTM)	6.23 %

Management Effectiveness
Return On Assets (TTM)	8.65 %
Return On Investment (TTM)	10.1 %
Return On Equity (TTM)	17.77 %
Dividend Yield	-
Payout Ratio (TTM)	33.85 %

• View Efficiency Comparisons

• View Profitability Comparisons

• View Management Effectiveness

Customers Net Income fell by	COV's customers Net margin fell to 19.02 %
-42.38 %	2.95 %

• Customers Performance

• Customers Expend.

• Customers Efficiency

• List of Customers

Reports on Competition

List of Competitors

Competitors by Segment

Segment Growth

Growth Rates

Suppliers At a Glance

List of Suppliers

Suppliers Performance

Major Competitors

Stock performance

5 Days	Decrease / Increase

BDX		3.2%
MDT		1.15%
PDCO		2%
BSX		2.07%
SYK		4.74%
MCK		4.11%
• View Complete Report

Tweet
Economy Advance Monthly Sales Consumer Price Index CPI Producer Price Index PPI Retail Inventories Personal Income Gross Domestic Product GDP Money Supply Industrial Production Productivity Employment Situation US International Trade Factory Orders Durable Goods Construction Spending Housing Starts Vehicle Unit Sales	Stocks Event Calendar DCAR's Profile Stock Price DCAR's Financials Business Description Fundamentals Charts & Quotes DCAR's News Suppliers DCAR's Competitors Customers & Markets Economic Indicators DCAR's Growth Company Segments	Screening Stock Performance Growth Rates Profitability Valuation Dividend Financial Strength Efficiency Largest Companies Management Effectivness

Help

Sitemap

Advertise

About us

Glossary

Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. Free Stock Market News Feeds

Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071

COV Company Profile

Clean Energy Technologies Inc announced fourth quarter operating loss of $-0.083499 millions

North American Nickel Inc announced fourth quarter operating loss of $-1.816186 millions

Marimed Inc announced first quarter operating income of $0.9944 millions

Losses Widen but Revenues Unchanged

Balance Labs Inc announced fourth quarter operating loss of $-0.105078 millions